fluorodeoxyglucose f18 has been researched along with Cancer of Pelvis in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (10.91) | 18.2507 |
2000's | 20 (36.36) | 29.6817 |
2010's | 25 (45.45) | 24.3611 |
2020's | 4 (7.27) | 2.80 |
Authors | Studies |
---|---|
Kim, CK; Kim, DH; Kim, SW; Lee, BC; Sung, DH; Yoon, YC | 1 |
Furuya, S; Hirata, K; Katoh, C; Kawauchi, K; Kobayashi, K; Manabe, O; Shiga, T; Watanabe, S | 1 |
Kumar, R; Rastogi, S; Shamim, SA; Yadav, D | 1 |
Ben Shimol, J; Davidson, T; Domachevsky, L; Dotan, Z; Fridman, E; Giladi, Y; Leibowitz, R; Rosenzweig, B | 1 |
Brillouet, S; Caselles, O; Chaltiel, L; Courbon, F; Dercle, L; Dierickx, LO; Zerdoud, S | 1 |
Abe, O; Hayashi, N; Maeda, E; Naganawa, S; Yasaka, K; Yoshikawa, T | 1 |
Aktas, B; Antoch, G; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Ruhlmann, V; Sawicki, LM; Schaarschmidt, BM; Umutlu, L | 1 |
Apter, S; Ben-Haim, S; Davidson, T; Felder, S; Komisar, O; Korach, J; Perri, T | 1 |
Bruna-Muraille, C; Dejust, S; Morland, D; Moubtakir, A; Richard, C | 1 |
Pan, C; Xie, D; Xu, Y; Yu, W; Zheng, M | 1 |
Ohmichi, M; Sasaki, S; Tanaka, T; Terai, Y; Tsuchihashi, H; Yamada, T; Yamamoto, K | 1 |
Guo, Q; Li, K; Sun, H | 1 |
Liu, C; Liu, E; Sun, T; Wang, S | 1 |
Eary, JF; Jones, RL; Lewis, DH; Yan, J | 1 |
Aktas, B; Beiderwellen, K; Buderath, P; Forsting, M; Grueneisen, J; Heusch, P; Kraff, O; Lauenstein, TC; Ruhlmann, V; Umutlu, L | 1 |
Herrmann, K; Kohan, AA; Mihaloew, H; Paspulati, RM; Sherertz, T | 1 |
Ahn, H; Hong, JH; Hong, S; Jeong, IG; Kim, CS; You, D | 1 |
Dang, Y; Hu, G; Huo, L; Li, F; Ma, Y | 1 |
Choi, YJ; Han, YM; Hwang, HS; Koh, SH; Park, HC | 1 |
Guo, Q; Liu, C; Ma, Q; Sun, H; Xin, J; Zhai, W; Zhang, S | 1 |
Wang, T; Xing, Y; Zhao, J | 1 |
Atmaca Saglik, B; Basoglu, T; Sahin, M; Ucak Semirgin, S; Yapici, O | 1 |
Hope, TA; Kaushik, SS; Larson, PE; Leynes, AP; Seo, Y; Shanbhag, DD; Wiesinger, F; Yang, J | 1 |
Aktas, B; Antoch, G; Deuschl, C; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Ruhlmann, V; Sawicki, LM; Suntharalingam, S; Umutlu, L | 1 |
Hayashi, T; Higashiyama, S; Kawabe, J; Kawamura, E; Kotani, J; Kurooka, H; Oe, A; Shiomi, S | 1 |
Almusa, O; Daly, B; Shreve, P | 1 |
Lin, WY; Sun, SS; Tsai, SC; Wang, KB | 1 |
Fan, W; Hu, Y; Lang, P; Lin, X; Sun, X; Zhang, X | 1 |
Castrejón, AS; García, AN; Muñoz, AP; Vicente, AM; Woll, PP | 1 |
de Geus-Oei, LF; de Rooy, JW; Flucke, UE; Hambrock, T; Schreuder, BW; van de Luijtgaarden, AC; van der Geest, IC; Vriens, D | 1 |
Bakir, B; Has, D; Iyibozkurt, C; Mudun, A; Ozel, S; Sanli, Y; Topuz, S; Turkmen, C; Unal, SN; Yavuz, E; Yilmaz, E | 1 |
Abramson, SJ; Grewal, RK; LaQuaglia, MP; Magnan, H; Merchant, MS; Meyers, PA; Price, AP | 1 |
Espiritu, JI; Segall, GM; Sung, J; Terris, MK | 1 |
Akhurst, T; Guillem, JG; Larson, SM; Mazumdar, M; Minsky, BD; Moore, HG | 1 |
Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Görges, R | 1 |
Alavi, A; Bhargava, P; Dadparvar, S; Guan, L; Reich, P; Yu, JQ; Zhuang, H | 1 |
Coleman, RE; Kitapci, MT | 1 |
Camatte, S; Jeffry, L; Kerrou, K; Lécuru, F; Lelievre, L; Metzger, U; Robin, F; Talbot, JN | 1 |
Cesnik, R; Frühwald, F; Leitha, T; Steiner, E | 1 |
Bomanji, JB; Croasdale, I; Dickson, JC; Ell, PJ; Groves, AM; Hain, SF; Kayani, I; Nagabushan, N; Syed, R; Townsend, C | 1 |
Poon, A; Saunder, TH; Yap, KK | 1 |
Castaldo, S; Delaloye, AB; Delaloye, JF; Jichlinski, P; Kamel, EM; Leisinger, HJ; Malterre, J; Meuwly, JY; Prior, JO; Vaucher, L | 1 |
García-Garzón, JR; Lomeña, F; López-Gandul, S; Pérez-Moure, G; Simó-Perdigó, M; Soler-Peter, M | 1 |
Chang-Yu, W; Chen, MT; Chen, YJ; Li, SH; Wang, SL | 1 |
Ak, I | 1 |
Inoue, M; Ito, M; Kawakami, S; Kihara, K; Kobayashi, T; Masuda, H; Numao, N | 1 |
Boughanim, M; Duvillard, P; Haie-Meder, C; Leboulleux, S; Lumbroso, J; Morice, P; Pham, CT; Rey, A; Schlumberger, M; Zafrani, Y | 1 |
Alpert, NM; Fischman, AJ; Goldberg, MA; Lee, MJ; Mueller, PR; Thrall, JH | 1 |
de Wit, M; Durig, J; Fiedler, W; Hossfeld, DK; Steffen, M | 1 |
Gupta, NC; Kim, CK | 1 |
Adler, LP; Faulhaber, PF; Leisure, GP; Miraldi, F; O'Donnell, JK; Vesselle, HJ | 1 |
Karwal, MW; Murphy, SP; Nathan, MA | 1 |
Eary, JF; Gold, P; Guinee, DG; Mankoff, DA; Samlowski, WE; Thompson, JA | 1 |
Czernin, J; Gambhir, SS; Huebner, RH; Park, KC; Phelps, ME; Schwimmer, J; Shepherd, JE | 1 |
Alavi, A; Liu, Y; Pourdehnad, M; Sinha, P; Yamamoto, AJ; Zhuang, H | 1 |
4 review(s) available for fluorodeoxyglucose f18 and Cancer of Pelvis
Article | Year |
---|---|
Lumbosacral plexopathy caused by the perineural spread of pelvic malignancies: clinical aspects and imaging patterns.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Pain; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
Diagnostic value of 18F-FDG PET/MRI in recurrent pelvis malignancies of female patients: a systematic review and meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pelvic Neoplasms; Positron-Emission Tomography; Recurrence | 2018 |
Positron emission tomography-magnetic resonance imaging in oncologic diseases of the male and female pelvis.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Genitalia, Female; Genitalia, Male; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pelvic Neoplasms; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Recurrence, Local; Pelvic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
2 trial(s) available for fluorodeoxyglucose f18 and Cancer of Pelvis
Article | Year |
---|---|
Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Therapeutic Irrigation; Tomography, X-Ray Computed; Urinary Bladder | 2010 |
Oral contrast medium in PET/CT: should you or shouldn't you?
Topics: Abdominal Neoplasms; Administration, Oral; Artifacts; Contrast Media; Diatrizoate Meglumine; Female; Fluorodeoxyglucose F18; Humans; Male; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
49 other study(ies) available for fluorodeoxyglucose f18 and Cancer of Pelvis
Article | Year |
---|---|
A convolutional neural network-based system to classify patients using FDG PET/CT examinations.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Artificial Intelligence; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neural Networks, Computer; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Thoracic Neoplasms; Young Adult | 2020 |
Pelvic Leiomyosarcoma With Splenic Metastasis and Response Assessment by 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Splenic Neoplasms; Treatment Outcome | 2020 |
Penile secondary lesions: a rare entity detected by PET/CT.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Tumor Burden | 2021 |
Evaluation of 2 diuretic 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography imaging protocols for intrapelvic cancer.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Young Adult | 2019 |
Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Early Detection of Cancer; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2017 |
Comparison of
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Neoplasms; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Whole Body Imaging | 2018 |
Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET/CT imaging.
Topics: Adult; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Ovary; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Young Adult | 2018 |
Periurethral Mass Mimicking Neoplasm After Injection of Macroplastique for Postprostatectomy Stress Incontinence: A Pitfall on 18F-FDG PET/CT.
Topics: Diagnosis, Differential; Dimethylpolysiloxanes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urethra; Urinary Incontinence, Stress | 2018 |
Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Uterine Cervical Neoplasms | 2018 |
Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Staging; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Tumor Burden; Uterine Cervical Neoplasms | 2019 |
Giant Melanotic Malignant Peripheral Nerve Sheath Tumor in the Pelvis: Contrast-Enhanced CT and 18F-FDG PET/CT Finding.
Topics: Adult; Contrast Media; Fluorodeoxyglucose F18; Humans; Male; Neurofibrosarcoma; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Impact of (18)F-FDG PET/CT imaging in therapeutic decisions for malignant solitary fibrous tumor of the pelvis.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Pelvis; Radionuclide Imaging; Solitary Fibrous Tumors | 2013 |
[(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.
Topics: Adult; Aged; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Staging; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Whole Body Imaging | 2015 |
FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2015 |
Solitary Plasmacytoma in the Renal Pelvis on 18F-FDG and 11C-Acetate PET/CT.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Incidental Findings; Kidney Pelvis; Male; Multimodal Imaging; Pelvic Neoplasms; Plasmacytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
Visual and quantitative comparison of (18)F-fluorodeoxyglucose PET/CT findings in the detection of pelvic tumor recurrence in colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies; ROC Curve | 2016 |
PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2016 |
Endometriosis Mimicking an Advanced Malignant Tumor.
Topics: Adult; Diagnosis, Differential; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
Topics: Adult; Aged; Aged, 80 and over; Catheters; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Pelvic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Vagina; Vaginal Neoplasms | 2016 |
Hybrid ZTE/Dixon MR-based attenuation correction for quantitative uptake estimation of pelvic lesions in PET/MRI.
Topics: Bone and Bones; Bone Density; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms | 2017 |
Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Neoplasms; Pelvis; Positron Emission Tomography Computed Tomography; Whole Body Imaging | 2017 |
A case of cavernous hemangioma in which malignancy was preoperatively excluded by FDG-PET.
Topics: Aged; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Male; Pelvic Neoplasms; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Unexpected accumulation of F-18 FDG in the urinary bladder after bladder irrigation and retrograde filling with sterile saline: a possible pitfall in PET examination.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Fluorodeoxyglucose F18; Humans; Incidental Findings; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Sodium Chloride; Therapeutic Irrigation; Urinary Bladder | 2009 |
Benign metastasizing leiomyoma identified using 18F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lung Neoplasms; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Uterine Neoplasms | 2010 |
F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2011 |
Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Topics: Abdominal Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Positron emission tomography for response assessment in desmoplastic small round cell tumor.
Topics: Abdominal Neoplasms; Adolescent; Desmoplastic Small Round Cell Tumor; Female; Fluorodeoxyglucose F18; Humans; Male; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2013 |
Fluorodeoxyglucose positron emission tomography studies in the diagnosis and staging of clinically advanced prostate cancer.
Topics: Abdominal Neoplasms; Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Pelvic Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
Topics: Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Pelvic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Rectal Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Diagnosis of labia metastasis by F-18 FDG PET and CT fusion imaging in sarcoma follow-up.
Topics: Adult; Diagnosis, Differential; Diagnostic Errors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Pelvic Neoplasms; Predictive Value of Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Subtraction Technique; Vulvar Neoplasms | 2003 |
Unrecognized renal transplants as a potential source of false-positive interpretation of FDG PET.
Topics: Adult; Aged; Diagnostic Errors; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Single-Blind Method; Tomography, Emission-Computed | 2003 |
Incidental detection of pigmented villonodular synovitis on FDG PET.
Topics: Back; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hip Joint; Humans; Incidental Findings; Melanoma; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Skin Neoplasms; Synovitis, Pigmented Villonodular; Tomography, Emission-Computed | 2003 |
Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG-PET.
Topics: Adult; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Pelvic Neoplasms; Peritonitis, Tuberculous; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
Use of FDG-PET in the differential diagnosis of a single bone lesion in ovarian cancer.
Topics: Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Pelvic Bones; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2004 |
Increased F-18 FDG skeletal muscle uptake secondary to altered weight bearing and the use of crutches.
Topics: Adult; Crutches; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Melanoma; Muscle, Skeletal; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Weight-Bearing | 2005 |
Forced diuresis improves the diagnostic accuracy of 18F-FDG PET in abdominopelvic malignancies.
Topics: Adult; Diuresis; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Male; Middle Aged; Neoplasm Staging; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2006 |
Intravenous furosemide injection during 18F-FDG PET acquisition.
Topics: Abdominal Neoplasms; Diuretics; Drug Combinations; Female; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Metastatic eccrine porocarcinoma detected on FDG PET/CT.
Topics: Carcinoma; Eccrine Glands; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Subtraction Technique; Sweat Gland Neoplasms; Tomography, X-Ray Computed | 2007 |
F-18 FDG imaging of an asymptomatic sacrococcygeal pilonidal sinus in a patient with malignant disease.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Unknown Primary; Pelvic Neoplasms; Pilonidal Sinus; Radionuclide Imaging; Radiopharmaceuticals; Sacrococcygeal Region; Sacrum | 2007 |
[Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report].
Topics: Carcinoma; Cystectomy; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Pelvic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2007 |
Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Staging; Para-Aortic Bodies; Pelvic Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2008 |
Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
Topics: Abdominal Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Deoxyglucose; Fluorodeoxyglucose F18; Hemangioma, Cavernous; Humans; Liver Neoplasms; Lymphoma, Non-Hodgkin; Pelvic Neoplasms; Tomography, Emission-Computed | 1993 |
Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha.
Topics: Acidosis, Lactic; Aged; Deoxyglucose; Fatal Outcome; Female; Fluorodeoxyglucose F18; Gastrointestinal Hemorrhage; Humans; Hypoglycemia; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Pelvic Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1996 |
Dependency of standardized uptake values of fluorine-18 fluorodeoxyglucose on body size: comparison of body surface area correction and lean body mass correction.
Topics: Abdominal Neoplasms; Body Constitution; Body Height; Body Surface Area; Body Weight; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Pelvic Neoplasms; Regression Analysis; Tomography, Emission-Computed | 1996 |
Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Adolescent; Aged; Artifacts; Catheterization; Constriction; Deoxyglucose; Diuretics; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Furosemide; Humans; Image Enhancement; Infusions, Intravenous; Kidney; Male; Middle Aged; Pelvic Neoplasms; Radiopharmaceuticals; Sodium Chloride; Tomography, Emission-Computed; Ureter; Urinary Bladder; Urinary Catheterization; Urinary Tract; Water-Electrolyte Balance | 1997 |
FDG-PET appearance of pelvic Castleman's disease.
Topics: Adult; Castleman Disease; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Pelvic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor.
Topics: Carcinoma, Renal Cell; Deoxyglucose; Diagnostic Errors; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Interleukin-2; Kidney Neoplasms; Middle Aged; Neoplasm, Residual; Pelvic Neoplasms; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Similar pelvic abnormalities on FDG positron emission tomography of different origins.
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Pelvic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |